
Sudeep Pharma makes a strong debut, lists at 24% premium to IPO price
The ₹895 crore IPO of Vadodara-based Sudeep Pharma was subscribed 93.72 times at close, attracting bids for over ₹58,700 crore through over 29.86 lakh applications.

The ₹895 crore IPO of Vadodara-based Sudeep Pharma was subscribed 93.72 times at close, attracting bids for over ₹58,700 crore through over 29.86 lakh applications.

The brokerage said Godrej Properties and Lodha are likely to post strong new launches and sales performance in the second half of FY26, making them…

Thyrocare Technologies had approved the issue of two bonus shares for every one share held by shareholders as on the record date, which is today,…

Gold surged to $4,189.61 and silver to $54.18 as US Federal Reserve rate cut bets rose to 87%, boosting global bullion. Indian prices held steady…

Medical equipment supplier Nureca, had see a sharp surge in its share price during the Covid-19 pandemic, hitting a record high of ₹2,316.6 in October…

The foreign brokerage believes the regulatory environment, which had previously been a key drag on the stock price in past, is incrementally getting better.

At the interbank foreign exchange market, the rupee opened at 89.41. It slipped further to trade at 89.43 against the greenback in initial deals, registering…

Kotak wrote in its note that even though the stock has corrected meaningfully, the drop is still not enough to offer an attractive entry point…

Promoter entities were sellers in blocks of Whirlpool of India and MTAR Tech, while Goldman Sachs was a seller in CarTrade Technologies.

Aequs aims to raise ₹921.81 crore through the IPO, which includes a fresh issue of shares and an offer for sale component.